Gene deletion studies reveal a critical role for prostamide/prostaglandin F 2α synthase in prostamide F 2α formation
Authors:
- Jacques A BertrandJBJacques A Bertrand
- David F. WoodwardDWDavid F. Woodward
- Joseph M SherwoodJSJoseph M Sherwood
- Alice SpenlehauerASAlice Spenlehauer
- Cristoforo SilvestriCSCristoforo Silvestri
- Fabiana PiscitelliFPFabiana Piscitelli
- Vincenzo Di MarzoVincenzo Di Marzo
- Maya YamazakiMYMaya Yamazaki
- Kenji SakimuraKSKenji Sakimura
- Kikuko WatanabeKWKikuko Watanabe
- Darryl R OverbyDODarryl R Overby
Preprint
Abstract
Prostamide / prostaglandin F synthase (PM/PGFS) is an enzyme with very narrow substrate specificity and is dedicated to the biosynthesis of prostamide and prostaglandin F 2α. The importance of this enzyme, relative to the aldoketoreductase (AKR) series, in providing functional tissue prostamide F 2α levels was determined by creating a line of PM/PGFS gene deleted mice. Deletion of the gene encoding PM/PGFS (fam213b) was accomplished by a two exon disruption. Prostamide F 2α levels in WT and PM/PGFS KO mice were determined by LC/MS/MS. Intraocular pressure was measured by tonometry and outflow facility was measured by the iPerfusion method in enucleated mouse eyes. Deletion of fam213b had no observed effect on behavior, appetite, or fertility. Intraocular pressure was significantly elevated by approximately 4 mmHg in PM/PGFS KO mice compared to littermate WT mice. No effect on pressure dependent outflow facility occurred, which is consistent with the typically reported prostanoid effect of increasing outflow through the unconventional pathway. The elevation of intraocular pressure caused by deletion of the gene encoding the PM/PGFS enzyme likely results from a diversion of the endoperoxide precursor pathway to provide increased levels of those prostanoids that raise intraocular pressure, namely prostaglandin D 2 (PGD 2 ), thromboxane A 2 (TxA 2 ). It follows that PM/PGFS may serve an important regulatory role in the eye by providing PGF 2α and prostamide F 2α to constrain the influence of those prostanoids that raise intraocular pressure.Keywords
This publication has 33 references indexed in Scilit:
- Recent Progress in Prostaglandin F2 Ethanolamide (Prostamide F2) Research and TherapeuticsPharmacological Reviews, 2013
- Identification of an antagonist that selectively blocks the activity of prostamides (prostaglandin‐ethanolamides) in the feline irisBritish Journal of Pharmacology, 2007
- Enzymatic formation of prostamide F2α from anandamide involves a newly identified intermediate metabolite, prostamide H2Journal of Lipid Research, 2005
- Synthesis of prostaglandin F ethanolamide by prostaglandin F synthase and identification of Bimatoprost as a potent inhibitor of the enzyme: new enzyme assay method using LC/ESI/MSArchives of Biochemistry and Biophysics, 2004
- Metabolism of the Endocannabinoids, 2-Arachidonylglycerol and Anandamide, into Prostaglandin, Thromboxane, and Prostacyclin Glycerol Esters and EthanolamidesJournal of Biological Chemistry, 2002
- Preclinical Efficacy of Travoprost, a Potent and Selective FP Prostaglandin Receptor AgonistJournal of Ocular Pharmacology and Therapeutics, 2001
- Expression of bovine lung prostaglandin F synthase in Escherichia coliBiochemical and Biophysical Research Communications, 1991
- Structural similarity of bovine lung prostaglandin F synthase to lens epsilon-crystallin of the European common frog.Proceedings of the National Academy of Sciences, 1988
- Stereospecific conversion of prostaglandin D2 to (5Z,13E)-(15S)-9 alpha-11 beta,15-trihydroxyprosta-5,13-dien-1-oic acid (9 alpha,11 beta-prostaglandin F2) and of prostaglandin H2 to prostaglandin F2 alpha by bovine lung prostaglandin F synthase.Proceedings of the National Academy of Sciences, 1986
- The effects of prostaglandin F2α in the human eyeGraefe's Archive for Clinical and Experimental Ophthalmology, 1985